EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

Stereotaxis’ Genesis Robotic Magnetic Navigation (RMN) system

News | Robotic Systems

National Institute of Cardiology Becomes First Hospital in Poland to Establish Advanced Robotic Program to Treat Heart Rhythm Disorders

April 1, 2022 – Stereotaxis, the global leader in innovative robotic technologies for the treatment of cardiac ...

March 31, 2022

The poster titled “Short term prediction of Atrial Fibrillation from ambulatory ECG using deep learning” presents results of a clinical study demonstrating that Cardiologs’ AI algorithm can predict the short-term risk of atrial fibrillation (AFib) based on single-lead Ambulatory electrocardiograms (ECGs) that show normal sinus rhythm.

News | Atrial Fibrillation

Cardiologs Announces Poster Presentation at ACC 2022

April 1, 2022 — Cardiologs announced a poster presentation at the 2022 American College of Cardiology (ACC) meeting in ...

April 01, 2022

The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held April 3-5 at the Bella Center in Copenhagen, Denmark and online. Explore the scientific program.

News | ESC

EHRA 2022: Cutting Edge Science in Heart Rhythm Disorders

March 31, 2022 — The annual congress of the European Heart Rhythm Association (EHRA), a branch of the ESC, will be held ...

March 31, 2022

Sponsored Content

Case Study | Cardiovascular Information Systems (CVIS)

Single-Database Cardiology Platform Drives Efficient Workflow and Improves Data Access

Washington Health System (WHS) provides healthcare services at more than 40 offsite locations across three counties in ...

April 01, 2021

Eko, a digital health company advancing heart and lung disease detection, has announced the launch of its newly-redesigned Eko App, which will transform patient interactions into an opportunity to screen for cardiovascular disease.

News | Heart Failure

Eko Launches Screening Solution to Help Catch Heart Disease Early

March 29, 2022 – Eko, a digital health company advancing heart and lung disease detection, has announced the launch of ...

March 29, 2022

News | Stroke

Stroke Caused by Hidden Atrial Fibrillation: Med Uni Graz Researchers Develop a Clinical Risk Score

March 14, 2022 – Stroke is an acute disease of the brain and the most common cause of permanent disability in adults in ...

March 11, 2022

News | Remote Monitoring

New Post-cryptogenic Stroke Remote Telemetry Study Demonstrates Increased Atrial Fibrillation Detection

March 13, 2022 – Philips has announced new research evaluating mobile cardiac outpatient telemetry (MCOT) as a first ...

March 11, 2022

Sponsored Content

Feature | ECG

A Double-Edged Sword: How Over-the-Counter ECG Devices are Impacting Cardiac Care

Apple created a stir when it announced in 2018 that its Apple Watch Series 4 was the first consumer health and fitness ...

March 11, 2020

People with a congenital heart defect who were hospitalized with COVID-19 infection were at higher risk for severe illness or death than those without a heart defect, according to new research published in the American Heart Association’s flagship, peer-reviewed journal Circulation.

News | Coronavirus (COVID-19)

People With Heart Defects May Be at a Greater Risk for Severe COVID-19 Illness

March 13, 2022 – People with a congenital heart defect who were hospitalized with COVID-19 infection were at higher risk ...

March 11, 2022

Point-of-care screening for atrial fibrillation (A-fib) using a new generation of handheld electrocardiogram (ECG) devices increased the rate of diagnosis in patients 85 and older, but failed to show similar results in those 65 and older, a study by Massachusetts General Hospital (MGH) has found.

News | Atrial Fibrillation

Handheld Devices for A-fib Screening May be Most Effective in the Oldest Adults During Primary Care Visits

March 9, 2022 – Point-of-care screening for atrial fibrillation (A-fib) using a new generation of handheld electrocardio ...

March 09, 2022

CIRCA S-CATH M esophageal temperature probe

News | EP Mapping and Imaging Systems

CIRCA Scientific Receives FDA Clearance for New Esophageal Temperature Probe

March 3, 2022 – CIRCA Scientific, Inc. has announced that its S-CATH M Esophageal Temperature Probe is now cleared for ...

March 03, 2022

Sponsored Content

Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device.

Feature | ECG

Moving Beyond Holter ECG: The Rise in Next Generation Technology

When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “The newer ECG devices we have now are so much less cumbersome. It’s like wearing a Band-Aid versus carrying a bulky device,” said the Greenwood, Mississippi internist. “My patients prefer the more comfortable, wire-free form factor, and the quality is as good as, or better, than the Holter,” continued Boler. “Plus, my patient compliance has increased. With the Holter, the leads sometimes come off. The patient may think the device isn’t working, so they take it off and we have to restart the process.”

February 19, 2020

iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the advancement of cardiac care, announced that the results of the KP-Rhythm2 study, titled “Diagnostic yield, outcomes and resource utilization with different ambulatory electrocardiographic monitoring strategies,” were published in the American Journal of Cardiology (AJC).

News | Atrial Fibrillation

Zio by iRhythm Shows Significantly Higher Documentation of Atrial Fibrillation and Atrial Flutter Compared to Holter Monitors, Event Monitors

February 28, 2022 – iRhythm Technologies, Inc., a leading digital healthcare solutions company focused on the ...

February 28, 2022

News | Heart Failure

Abbott’s CardioMEMS HF System Receives FDA Approval to Support Patients Battling Earlier-Stage Heart Failure

February 25, 2022 – Abbott has announced that the U.S. Food and Drug Administration (FDA) has approved an expanded ...

February 25, 2022

A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart arrhythmia diagnosis in clinical practice — has debuted at UC San Diego Health. vMap is a non-invasive, computational mapping system that produces a three-dimensional, interactive map of arrhythmia hotspots anywhere in the heart, including all four chambers of the organ, the septal wall and the outflow tracts.

News | Atrial Fibrillation

Remapping Atrial Fibrillation Treatment

February 16, 2022 – A new way of treating arrhythmias, including atrial fibrillation (AF) — the most common heart ...

February 16, 2022

Sponsored Content

Most professional athletes participate in cardiovascular screening to identify often-asymptomatic heart disorders, but the debate continues on whether to mandate ECGs as part of pre-participation screening for student athletes. Photo courtesy of Play for Patrick.

Feature | Sudden Cardiac Arrest

As Interpretation Criteria Evolve, False Positive Athlete ECG Screening Rates Can Decrease

Sudden cardiac death (SCD) is the leading medical cause of death in young athletes and its impact is consistent worldwide. Most professional athletes in the United States are required to take part in comprehensive cardiovascular screening programs to identify often-asymptomatic congenital or inherited heart disorders, and other cardiac risk factors. There remains a debate however, whether to mandate ECGs as part of pre-participation screening programs for student athletes at the collegiate and high school levels or even at younger ages.

October 16, 2018